Ontology highlight
ABSTRACT: Rationale
Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually. Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initiation. Inadequate treatment leads to worsening disease, disease transmission and drug resistance.Objectives
To determine if blood transcriptional signatures change in response to antituberculosis treatment and could act as early biomarkers of a successful response.Methods
Blood transcriptional profiles of untreated active tuberculosis patients in South Africa were analysed before, during (2 weeks and 2 months), at the end of (6 months) and after (12 months) antituberculosis
SUBMITTER: Bloom CI
PROVIDER: S-EPMC3462772 | biostudies-literature | 2012
REPOSITORIES: biostudies-literature